Page 176 - Immunization Practices News Today

SHIPMENT EXPECTED SOON: The vaccine is advised for people aged 65 and older, immunocompromised people aged 18 and older, and people at high risk of infection/ Staff writer, with CNA

Federal authorities authorized the use of new updated bivalent COVID-19 boosters for people 12 and older, and the updated boosters are expected to be available in Oregon as early as next week. The Centers for Disease Control and Prevention today endorsed a recommendation by its Advisory Committee on Immunization Practices and approved both the Pfizer and Moderna bivalent boosters for use. The recommendation comes after the U.S. Food and Drug Administration issued an Emergency Use Authorization (...

Quotable quotes heard by <em>MedPage Today</em>'s reporters

More than 55 percent of children ages 6 months to 2 years of age had a systemic reaction, ...

The Food and Drug Administration has authorized updated COVID booster shots of Moderna and Pfizer-BioNTech that target the highly contagious BA.5 omicron subvariant of the deadly coronavirus.

CDC advisors somewhat reluctantly voted in support of new bivalent versions of COVID-19 vaccines despite a lack of clinical trial data, CDC director follows suit.

The Centers for Disease Control and Prevention recommended that millions of eligible Americans, including those as young as 12, get an updated omicron-targeting booster shot to bolster defenses against serious illness and death during a potential fall or winter rise in COVID-19 cases.

The vote is one of the last steps before millions of the retooled shots roll out by the end of this weekend as part of a nationwide revaccination campaign. The agency's Director Rochelle Walensky will make the final call after the meeting. He has been supportive of a booster campaign in recent public statements.

Redesigned Omicron boosters will be available to millions of people by the end of the weekend as part of a nationwide revaccination campaign.

Advisers to the US Centers for Disease Control and Prevention on Thursday voted to recommend the use of COVID-19 booster shots redesigned to target the BA.4 and BA.5 Omicron subvariants of the coronavirus for people aged 12 years and older.